NM
Neumora Therapeutics, Inc. Common Stock
NMRA · NASDAQ
$0.73 -1.48% (-$0.01)
1M -55.21%
Market Cap $139.0M
P/E Ratio -
Div. Yield -
ROE 242.29%
Bulios Fair Price
$0.97
32.9% upside
Trenutna cena
$0.73
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica NMRA trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
65 /100
Fair P/B 3.12x
EV/EBITDA N/A
P/S N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 242.29%
ROA 169.86%
Asset turnover 0.00x
Debt
69 /100
Low Current ratio 4.50x
Int. coverage -32.09x
Debt/Equity 0.01x
Stability
21 /100
Unstable EPS volatility 43.21%
Profitable years 0
Beta 2.74x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NMRA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Josh Pinto
Employees
63
Headquarters
Watertown
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report